Adherence to antipsychotics among Latinos and Asians with schizophrenia and limited English proficiency

Psychiatric Services

Volumn 60, Issue 2, 2009, Pages 175-182

  Gilmer, Todd P ^a   Ojeda, Victoria D ^a   Barrio, Concepcion ^b   Fuentes, Dahlia ^b   Garcia, Piedad ^c   Lanouette, Nicole M ^d   Lee, Kelly C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c San Diego County Adult and Older Adult Mental Health Services   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 59649127406     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/ps.2009.60.2.175     Document Type: Article

References (37)

1. Fenton WS, Blyler CR, Heinssen RK: Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophrenia Bulletin 23:637-651, 1997
2. Svarstad BL, Shireman TI, Sweeney JK: Using drug claims data to assess the relationship of medication adherence with hospitalization and costs. Psychiatric Services 52:805-811, 2001
3. Valenstein M, Copeland LA, Blow FC, et al: Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Medical Care 40:630-639, 2002
4. Lacro JP, Dunn LB, Dolder CR, et al: Prevalence of and risk factors for medication nonadherence inpatients with schizophrenia: a comprehensive review of recent literature. Journal of Clinical Psychiatry 63:892-909, 2002
5. Dolder CR, Lacro JP, Jeste DV: Adherence to antipsychotic and nonpsychiatric medications in older patients with psychotic disorders. Psychosomatic Medicine 65:156-162, 2003
6. Gilmer TP, Dolder CR, Lacro JP, et al: Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. American Journal of Psychiatry 161:692-699, 2004
7. Valenstein M, Ganoczy D, McCarthy JF, et al: Antipsychotic adherence over time among patients receiving treatment for schizophrenia: a retrospective review. Journal of Clinical Psychiatry 67:1542-1550, 2006
8. Terkelsen KG, Menikoff A: Measuring the costs of schizophrenia: implications for the post-institutional era in the US. Pharmacoeconomics 8:199-222, 1995
9. Ascher-Svanum H, Faries DE, Zhu B, et al: Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. Journal of Clinical Psychiatry 67:453-460, 2006
10. Weiden PJ, Olfson M: Cost of relapse in schizophrenia. Schizophrenia Bulletin 21:419-429, 1995
11. Marcus SC, Olfson M: Outpatient antipsychotic treatment and inpatient costs of schizophrenia. Schizophrenia Bulletin 34:173-180, 2007
12. Sun SX, Liu GG, Christensen DB, et al: Review and analysis of hospitalization costs associated with antipsychotic nonadherence in the treatment of schizophrenia in the United States. Current Medical Research and Opinion 23:2305-2312, 2007
13. Osterberg L, Blaschke T: Adherence to medication. New England Journal of Medicine 353:487-497, 2005
14. Lacro JP, Dunn LB, Dolder CR, et al: Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. Journal of Clinical Psychiatry 63:892-909, 2002
15. Tarn DM, Heritage J, Paterniti DA, et al: Physician communication when prescribing new medications. Archives of Internal Medicine 166:1855-1862, 2006
16. Nielsen-Bohlman L, Panzer A, Kindig DA, et al: Health Literacy: A Prescription to End Confusion. Washington, DC, National Academies Press, 2004
17. Diaz E, Woods SW, Rosenheck R: Effects of ethnicity on psychotropic medications adherence. Community Mental Health Journal 41:521-537, 2005
18. Opolka JL, Rascati KL, Brown CM, et al: Role of ethnicity in predicting antipsychotic medication adherence. Annals of Pharmacotherapy 37:625-630, 2003
19. San Diego Region Fast Facts. San Diego, San Diego Association of Governments, Aug 2006
20. Ramirez Garcia JI, Chang CL, Young JS, et al: Family support predicts psychiatric medication usage among Mexican American individuals with schizophrenia. Social Psychiatry and Psychiatric Epidemiology 41:624-631, 2006
21. Barrio C, Palinkas LA, Yamada AM, et al: Unmet needs for mental health services for Latino older adults: perspectives from consumers, family members, advocates, and service providers. Community Mental Health Journal 44:57-74, 2007
22. Folsom D, Gilmer T, Barrio C, et al: A longitudinal study of the use of mental health services by persons with serious mental illness: do Spanish-speaking Latinos differ from English-speaking Latinos and Caucasians? American Journal of Psychiatry 164:1173-1180, 2007
23. Gilmer TP, Ojeda VD, Folsom DP, et al: Initiation and use of public mental health services by persons with severe mental illness and limited English proficiency. Psychiatric Services 58:1555-1562, 2007
24. California Health Interview Survey, 2005. Available at www.chis.ucla.edu
25. Kronick R, Gilmer T, Dreyfus T, et al: Improving health-based payment for Medicaid beneficiaries: CDPS. Health Care Financing Review 21:29-64, 2000
26. Efron B: An Introduction to the Bootstrap. New York, Chapman & Hall, 1993
27. Blough DK, Madden CW, Hornbrook MC: Modeling risk using generalized linear models. Journal of Health Economics 18:153-171, 1999
28. Manning WG: The logged dependent variable, heteroscedasticity, and the retransformation problem. Journal of Health Economics 17:283-285, 1998
29. Schmidley AD: Profile of the Foreign-Born Population in the United States: 2000. Washington, DC, US Census Bureau, 2001
30. Kopelowicz A, Zarate R, Gonzalez Smith V, et al: Disease management in Latinos with schizophrenia: a family-assisted, skills training approach. Schizophrenia Bulletin 29:211-217, 2003
31. Kim SW, Yoon JS, Choi SK: Survey of medication adherence in patients with schizophrenia: Korean ADHES data. Human Psychopharmacology 21:533-537, 2006
32. Li WW, Stewart AL, Stotts N, et al: Cultural factors associated with antihypertensive medication adherence in Chinese immigrants. Journal of Cardiovascular Nursing 21:354-362, 2006
33. Ponce NA, Ku L, Cunningham WE, et al: Language barriers to health care access among Medicare beneficiaries. Inquiry 43:66-76, 2006
34. Smith M, Lin K, Mendoza R: "Nonbiological issues" affecting psychopharmacotherapy: cultural considerations, in Psychopharmacology and Psychobiology of Ethnicity. Edited by Lin K, Poland R, Nakasaki G. Washington DC, American Psychiatric Press, 1993
35. Lin KM, Cheung F: Mental health services for Asian Americans. Psychiatric Services 48:539-540, 1999
36. Ngo-Metzger Q, Massagli MP, Clarridge BR, et al: Linguistic and cultural barriers to care. Journal of General Internal Medicine 18:44-52, 2003
37. Ngo-Metzger Q, Sorkin DH, Phillips RS, et al: Providing high-quality care for limited English proficient patients: the importance of language concordance and interpreter use. Journal of General Internal Medicine S2:324-330, 2007